re: News: Biotron's Hep C drug candidate phas... Very, very exciting prospect here IMO (for the hearing impaired)
Dr.Michelle Miller CEO
"regulatory authorities such as the FDA in the US have been really clear in saying they are very keen to see trials quickly, and development through the market quickly, in difficult to treat hepatitis C populations and one of those groups is the HIV and HCV co-infected populations. Up to 30% of HIV patients are also are also infected with Hep C".
"Biotron is in the unique position of having this drug BIT-225 which has activity against both HIV and Hepatitis C".
Bring on the deal/s !!!
Cheers,
FF
- Forums
- ASX - By Stock
- News: Biotron's Hep C drug candidate phase 2a tri
re: News: Biotron's Hep C drug candidate phas... Very, very...
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BIT (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $17.14M |
Open | High | Low | Value | Volume |
1.9¢ | 2.0¢ | 1.9¢ | $6.369K | 330.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 847148 | 1.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.0¢ | 1129029 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 847148 | 0.019 |
10 | 1774771 | 0.018 |
9 | 934388 | 0.017 |
12 | 3734154 | 0.016 |
10 | 1205000 | 0.015 |
Price($) | Vol. | No. |
---|---|---|
0.020 | 1129029 | 5 |
0.021 | 500000 | 1 |
0.022 | 997769 | 4 |
0.023 | 1449422 | 4 |
0.024 | 153949 | 2 |
Last trade - 16.10pm 30/09/2024 (20 minute delay) ? |
Featured News
BIT (ASX) Chart |